Figure 1. Correlation between weekly percentage changes in pulmonary artery pressure and thoracic impedance.
| Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
| Journal website https://www.cardiologyres.org |
Original Article
Volume 14, Number 1, February 2023, pages 32-37
Assessing Correlation Between Thoracic Impedance and Remotely Monitored Pulmonary Artery Pressure in Chronic Systolic Heart Failure
Figures
Table
| ACE-I: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker; BMI: body mass index; SD: standard deviation. | |
| N | 9 |
| Age (mean ± SD), years | 74 ± 9 |
| Male gender (n, %) | 5 (59%) |
| BMI (mean ± SD), kg/m2 | 31.7 ± 6.3 |
| Smoking (n, %) | |
| Never smoker | 3 (41%) |
| Current smoker | 1 (11%) |
| Former smoker | 5 (55%) |
| Hypertension (n, %) | 9 (100%) |
| Hyperlipidemia (n, %) | 9 (100%) |
| Diabetes mellitus (n, %) | 5 (55%) |
| Coronary artery disease (n, %) | 7 (82%) |
| Peripheral arterial disease (n, %) | 1 (11%) |
| Atrial fibrillation/other arrhythmias (n, %) | 3 (41%) |
| Chronic kidney disease (n, %) | 2 (23%) |
| Medications (N = 9) | |
| Beta-blockers (n, %) | 9 (100%) |
| ACE-I or ARB (n, %) | 3 (41%) |
| ARB/neprilysin inhibitor (n, %) | 4 (44%) |
| Aldosterone receptor blocker (n, %) | 6 (67%) |
| Diuretics (n, %) | 9 (100%) |
| Other vasodilators (n, %) | 1 (11%) |
| Digoxin (n, %) | 1 (11%) |